Physician profile
Jessica B Hobby
NPI 1093135956
$40,001.62
in general payments reported to CMS, 2019-2025
24 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,635 · 2020: $305 · 2021: $1,293 · 2022: $3,058 · 2023: $371 · 2024: $15K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $3,704 · Travel and Lodging: $954 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $24,044.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $3,703.97 |
| Travel and Lodging | $953.88 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $38,047.21 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $980.95 | 2019-2025 | Perclot, Recothrom, Tisseel |
| Conmed Corporation | $137.58 | 2023-2024 | Airseal |
| Baudax Bio INC. | $93.71 | 2021-2022 | |
| Tela Bio, INC. | $90.01 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Glaxosmithkline, LLC. | $80.20 | 2024 | |
| W. L. Gore & Associates, INC. | $79.27 | 2024-2025 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Organogenesis INC. | $59.43 | 2025 | Puraply Wound Matrix |
| Enterra Medical, INC. | $57.16 | 2022-2025 | |
| Stryker Corporation | $45.24 | 2025 | Stryker |
| Abiomed | $41.80 | 2023-2024 | Impella |
| Haemonetics Corporation | $39.30 | 2023 | Teg6s Hemostasis System |
| Innovation Technologies INC | $32.45 | 2025 | Irrisept |
| Abbvie INC. | $29.98 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Hologic Sales and Service, LLC | $26.45 | 2025 | Magtrace, Magseed |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $24.65 | 2023 | Aquadex Smartflow Console |
| Vertex Pharmaceuticals Incorporated | $24.04 | 2024 | |
| Leica Microsystems INC. | $19.98 | 2022 | |
| Elucent Medical | $18.90 | 2025 | |
| Davol INC. | $18.20 | 2025 | Arista |
| Acera Surgical, INC. | $15.70 | 2022 | |
| Bioptics, INC. | $14.58 | 2021 | |
| La Jolla Pharmaceutical Company | $13.63 | 2024 | Xerava |
| Boston Scientific Corporation | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Hobby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.